Q3 2023 Results slide image

Q3 2023 Results

Company overview Financial review Conclusions Innovation: Pipeline overview Financial performance Cardiovascular Immunology Neuroscience Ophthalmology Global Health Appendix Innovation: Clinical trials Oncology Global Health References Abbreviations Other 80 Investor Relations | Q3 2023 Results 1 NOVARTIS | Reimagining Medicine
View entire presentation